Efficacy and safety of pembrolizumab in patients with advanced urothelial carcinoma deemed potentially ineligible for platinum‐containing chemotherapy: Post hoc analysis of KEYNOTE‐052 and LEAP‐011

Documenti analoghi

• Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP‐005 study recurrent glioblastoma cohort
  di: Sun Young Rha, et al.
  Pubblicazione: (2025)
• Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple‐negative breast cancer: Results from the triple‐negative breast cancer cohort of the phase 2 LEAP‐005 Study
  di: Hyun Cheol Chung, et al.
  Pubblicazione: (2024)
• Long‐term follow‐up results from KEYNOTE‐041: Phase 1b study of pembrolizumab in Japanese patients with advanced melanoma
  di: Kenji Yokota, et al.
  Pubblicazione: (2024)
• Tracking and managing deemed abilities
  di: Troquard, Nicolas
  Pubblicazione: (2021)
• Characterizations of Lipschitz functions via the commutators of maximal function in total Morrey spaces
  di: Vagif S. Guliyev
  Pubblicazione: (2024)